Summary-
A new market study,”Global Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Region: Trend Forecast and Growth Opportunity” has been featured on WiseGuyReports.

Global pharmaceutical continuous manufacturing market will reach $2,665.5 million by 2030, growing by 10.5% annually over 2020-2030 driven by advantages offered by continuous manufacturing process such as cost saving and improved productivity.
Highlighted with 85 tables and 76 figures, this 173-page report “Global Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global pharmaceutical continuous manufacturing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global pharmaceutical continuous manufacturing market in every aspect of the classification from perspectives of Product, Application, End User, and Region.

ALSO READ: https://www.medgadget.com/2020/10/pharmaceutical-continuous-manufac...

Based on Product, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Integrated Continuous Systems
Semi-Continuous Systems
• Continuous Granulators
• Continuous Blenders
• Continuous Compressors
• Continuous Coaters
• Continuous Dryers
• Other Semi-Continuous Systems
Controls & Software

Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
End Product Manufacturing
• Solid Dosage Manufacturing
• Liquid Dosage Manufacturing
API Manufacturing

Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Pharmaceutical Companies
• Contract Manufacturing Organizations
• Research Organizations and Institutes
• Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (Saudi Arabia, UAE, South Africa)
For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product, Technology, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global pharmaceutical continuous manufacturing market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebrüder Lödige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

FOR MORE DETAILS: https://www.wiseguyreports.com/reports/5902512-global-pharmaceutica...

ABOUT US
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Contact Us:
NORAH TRENT
[email protected]
Ph: +162-825-80070 (US)
Ph: +44 203 500 2763 (UK)